Skip to main content
. 2018 Apr 16;32(4):281–287. doi: 10.7555/JBR.31.20160116

Fig.1.

Fig.1

The effect of pitavastatin on AGEs-induced ROS. Intracellular ROS levels were assessed using DCFH-DA probe. Intensity alterations in ROS generation. Data represented are mean±SD of three independent experiments. *P < 0.01. AGE: advanced glycation end products; ROS: reactive oxygen species; Pit: pitavastatin.